News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Psilocybin shows promise in relieving depression in cancer patients
08 May 2023
byChristina Lau
The 5-HT2A receptor agonist psilocybin, when taken under medical supervision, may offer a promising approach to treatment of major depressive disorder (MDD) in cancer patients, results of a small phase II study suggest.
08 May 2023

Longer time spent in any physical activity tied to lower T2DM risk
07 May 2023
The longer the duration individuals engage in any type of physical activity intensity, the lower their risk of developing type 2 diabetes mellitus (T2DM), regardless of age, sex, body mass index (BMI), or sedentary time, according to a recent study.
07 May 2023

Bisphosphonate, denosumab not linked to acute cardiovascular risk
06 May 2023
Use of oral bisphosphonate or denosumab does not appear to increase the risk of cardiovascular events (CVEs), namely acute myocardial infarction, unstable angina, cerebrovascular accident, and transient ischemic attack, in persons with incident fracture, a study has shown.
06 May 2023





